Thursday, April 21, 2016
St. Jude Medical Inc reported a 7.6 percent rise in quarterly revenue, helped by higher sales in its heart failure and neuromodulation businesses.
For the first quarter ended April 2, earnings attributable to the company fell to $95 million, or 33 cents per share, from $262 million, or 91 cents per share a year earlier.
In the quarter, the company recognized net after-tax charges of $164 million, or $0.57 per share, primarily related to acquisition-related costs and restructuring activities.
The company's total sales rose to $1.45 billion from $1.35 billion.
Source : reuters.com
